Aptamers in targeted nanotherapy

Current Topics in Medicinal Chemistry

Volumn 15, Issue 12, 2015, Pages 1102-1114

  Mathew, Anila ^a   Maekawa, Toru ^a   Sakthikumar, D ^a  

^a TOYO UNIVERSITY   (Japan)

Author keywords

Aptamers; Nanomedicine; Nanotherapy; Targeting

Indexed keywords

APTAMER; BCL2 RELATED PROTEIN A1; CD30 ANTIGEN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERYTHROCYTE MEMBRANE PROTEIN 1; LIPOCORTIN 2; MUCIN 1; PACLITAXEL; PEGAPTANIB; PORPHYRIN DERIVATIVE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN BCL XL; ANTINEOPLASTIC ANTIBIOTIC; MOLECULAR LIBRARY; NANOPARTICLE; PEPTIDE APTAMER;

ARTICLE; CANCER THERAPY; CAPILLARY ELECTROPHORESIS; COMBINATORIAL CHEMISTRY; CYTOTOXICITY; DNA SEQUENCE; DRUG DELIVERY SYSTEM; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOTHERAPY; NANOMEDICINE; NONHUMAN; PROTEIN EXPRESSION; RADIOSENSITIZATION; ANIMAL; CHEMISTRY; MALE; MOLECULAR IMAGING; MOLECULAR LIBRARY; MOLECULARLY TARGETED THERAPY; MOUSE; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; THERANOSTIC NANOMEDICINE; THERAPEUTIC USE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APTAMERS, NUCLEOTIDE; APTAMERS, PEPTIDE; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; MALE; MICE; MOLECULAR IMAGING; MOLECULAR TARGETED THERAPY; NANOPARTICLES; PROSTATIC NEOPLASMS; SELEX APTAMER TECHNIQUE; SMALL MOLECULE LIBRARIES; THERANOSTIC NANOMEDICINE;

EID: 84988662637     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150413153525     Document Type: Article

References (107)

1. Chen, H.; Zheng, X.; Di, B.; Wang, D.; Zhang, Y.; Xia, H.; Mao, Q. Aptamer Modification Improves the Adenoviral Transduction of Malignant Glioma Cells. J. Biotechnol., 2013, 168(4), 362–366.
2. Shi, H.; He, X.; Wang, K.; Wu, X.; Ye, X.; Guo, Q.; Tan, W.; Qing, Z.; Yang, X.; Zhou, B. Activatable Aptamer Probe for Contrast- Enhanced in Vivo Cancer Imaging Based on Cell Membrane Protein-Triggered Conformation Alteration. Proc. Natl. Acad. Sci. U S A., 2011, 108(10), 3900–3905.
3. Hoppe-Seyler, F.; Crnkovic-Mertens, I.; Tomai, E.; Butz, K. Peptide aptamers: specific inhibitors of protein function. Curr. Mol. Med., 2004, 4(5), 529–538.
4. Kunz, C.; Borghouts, C.; Buerger, C.; Groner, B. Peptide Aptamers with Binding Specificity for the Intracellular Domain of the ErbB2 Receptor Interfere with AKT Signaling and Sensitize Breast Cancer Cells to Taxol. Mol. Cancer Res., 2006, 4(12), 983–998.
5. Brien, G.; Debaud, A.L.; Bickle, M.; Trescol-Biemont, M.C.; Moncorgé, O.; Colas, P.; Bonnefoy-Bérard, N. Characterization of Peptide Aptamers Targeting Bfl-1 Anti-Apoptotic Protein. Biochemistry, 2011, 50(23), 5120–5129.
6. Varmira, K.; Hosseinimehr, S.J.; Noaparast, Z.; Abedi, S.M. A HER2-Targeted RNA Aptamer Molecule Labeled with 99mTc for Single-Photon Imaging in Malignant Tumors. Nucl. Med. Biol., 2013, 40(8), 980–986.
7. Taghdisi, S.M.; Lavaee, P.; Ramezani, M.; Abnous, K. Reversible Targeting and Controlled Release Delivery of Daunorubicin to Cancer Cells by Aptamer-Wrapped Carbon Nanotubes. Eur. J. Pharm. Biopharm., 2011, 77(2), 200–206.
8. Queirós, R.B.; de-los-Santos-Álvarez N.; Noronha, J.P.; Sales, M.G.F. A Label-Free DNA Aptamer-Based Impedance Biosensor for the Detection of E. Coli Outer Membrane Proteins. Sens. Actuators B. Chem., 2013, 181, 766–772.
9. Guthrie, J.; Hamula, C.; Zhang, H.; Le, X. Assays for cytokines using aptamers. Methods, 2006, 38(4), 324–330.
10. Ulrich, H. DNA and RNA aptamers as modulators of protein function. Med. Chem., 2005, 1(2), 199–208.
11. Lee, S.; Kim, Y. S.; Jo, M.; Jin, M.; Lee, D.; Kim, S. Chip-Based Detection of Hepatitis C Virus Using RNA Aptamers That Specifically Bind to HCV Core Antigen. Biochem. Biophys. Res. Commun., 2007, 358(1) 47–52.
12. Lee, Y.J.; Han, S.R.; Maeng, J.S.; Cho, Y.J.; Lee, S.W. In Vitro Selection of Escherichia Coli O157: H7-Specific RNA Aptamer. Biochem. Biophys. Res. Commun., 2012, 417(1), 414–420.
13. Kim, Y.S.; Song, M.Y.; Jurng, J.; Kim, B.C. Isolation and Characterization of DNA Aptamers against Escherichia Coli Using a Bacterial Cell–systematic Evolution of Ligands by Exponential Enrichment Approach. Anal. Biochem., 2013, 436(1), 22–28.
14. Suh, S. H.; Dwivedi, H.; Jaykus, L.A. Development and Evaluation of Aptamer Magnetic Capture Assay in Conjunction with Real- Time PCR for Detection of Campylobacter jejuni. LWT - Food Sci. Tech., 2014, 56(2), 256–260.
15. Zhou, C.; Chen, T.; Wu, C.; Zhu, G.; Qiu, L.; Cui, C.; Hou, W.; Tan, W. Aptamer CaCO 3 Nanostructures: A Facile, pHResponsive, Specific Platform for Targeted Anticancer Theranostics. Chem. Asian J., 2015, 10(1)166-171 .
16. Rosenberg, J.; Bambury, R.; Allen, E.; Drabkin, H.; Lara, P.; Harzstark, A.; Wagle, N.; Figlin, R.; Smith, G.; Garraway, L.; Choueiri, T.; Erlandsson, F.; Laber, D. A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Invest. New Drugs, 2013, 32(1), 178–187.
17. Chen, X.; Estévez, M.C.; Zhu, Z.; Huang, Y.F.; Chen, Y.; Wang, L.; Tan, W. Using Aptamer-Conjugated Fluorescence Resonance Energy Transfer Nanoparticles for Multiplexed Cancer Cell Monitoring. Anal. Chem., 2009, 81(16), 7009–7014.
18. Bruno, J. G. Aptamer–biotin–streptavidin–C1q Complexes Can Trigger the Classical Complement Pathway to Kill Cancer Cells. In Vitro Cell. Dev. Biol. Anim., 2009, 46(2), 107–113.
19. Zhang, J.; Jia, X.; Lv, X.J.; Deng, Y.L.; Xie, H.Y. Fluorescent Quantum Dot-Labeled Aptamer Bioprobes Specifically Targeting Mouse Liver Cancer Cells. Talanta, 2010, 81(1-2), 505–509.
20. Nam, K.; Eom, K.; Yang, J.; Park, J.; Lee, G.; Jang, K.; Lee, H.; Lee, S. W.; Yoon, D. S.; Lee, C. Y.; Kwon, T. Aptamerfunctionalized nano-pattern based on carbon nanotube for sensitive, selective protein detection. J. Mat. Chem., 2012, 22, 23348-23356.
21. Fan, Z.; Khan, S.A.; Dai, X.; Tchouwou, C.; Lu, Y.; Ray, P.C. Theranostic Nanoplatforms for MRSA Detection and Destruction from Whole Blood. Part. Part. Syst. Charact. 2013, 31(3), 357–364.
22. Li, J.; You, J.; Dai, Y.; Shi, M.; Han, C.; Xu, K. Gadolinium Oxide Nanoparticles and Aptamer-Functionalized Silver Nanoclusters- Based Multimodal Molecular Imaging Nanoprobe for Optical/ Magnetic Resonance Cancer Cell Imaging. Anal. Chem., 2014, 86(22), 11306–11311.
23. Zhang, X.; Zhang, J.; Yanyun S; Pei, X.; Liu, Q.; Lu, B.; Jin, L.; Wang, J.; Liu, J. A Cell-Based Single-Stranded DNA Aptamer Specifically Targets Gastric Cancer. Int. J. Biochem. Cell Biol., 2014, 46, 1–8.
24. Shi, H.; Tang, Z.; Kim, Y.; Nie, H.; Huang, Y. F.; He, X.; Deng, K.; Wang, K.; Tan, W. In Vivo Fluorescence Imaging of Tumors Using Molecular Aptamers Generated by Cell-SELEX. Chem. Asian J., 2010, 5(10), 2209–2213.
25. Tombelli S.; Minunni M.; Mascini M. Analytical Applications of Aptamers. Biosens. Bioelectron., 2005, 20(12), 2424–2434.
26. Shangguan D.; Li Y.; Tang Z.; Cao, Z.C.; Chen, H.W.; Mallikaratchy P.; Sefah K.; Yang, C.J.; Tan W. Aptamers Evolved from Live Cells as Effective Molecular Probes for Cancer Study. Proc. Natl. Acad. Sci. U.S.A., 2006, 103(32), 11838–11843.
27. Zhou, J.; Bobbin, M.L.; Burnett, J.C.; Rossi, J.J. Current Progress of RNA Aptamer-Based Therapeutics. Front. Genet., 2012, 3, 234.
28. Xie, S.; Walton, S.P. Development of a Dual-Aptamer-Based Multiplex Protein Biosensor. Biosens. Bioelectron., 2010, 25(12), 2663–2668.
29. Luo, Y.; Liu, X.; Jiang, T.; Liao, P.; Fu, W. Dual-Aptamer-Based Biosensing of Toxoplasma Antibody. Anal. Chem., 2013, 85(17), 8354–8360.
30. Maeng, J.S.; Kim, N.; Kim, C.T.; Han, S.R.; Lee, Y.J.; Lee, S.W.; Lee, M.H.; Cho, Y.J. Rapid Detection of Food Pathogens Using RNA Aptamers-Immobilized Slide. J. Nanosci. Nanotechnol., 2012, 12(7), 5138–5142.
31. Sun, H.; Zhu, X.; Lu, P.Y.; Rosato, R.R.; Tan, W.; Zu, Y. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy. Mol. Ther. Nucleic Acids, 2014, 3, e182.
32. Bruno, J.G. A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches. Pharmaceuticals (Basel), 2013, 6(3), 340–357.
33. Hicke, B.J.; Stephens, A.W.; Gould, T.; Chang Y.F.; Lyncott, C.K.; Heil, J.; Borkowski, S.; Hilger, C.S.; Cook, G.; Warren, S.; Schmidt, P.G. Tumor targeting by an aptamer. J. Nucl. Med., 2006, 47(4), 668-678.
34. Ray, P.; Viles, K.D.; Soule, E.E.; Woodruff, R. S. Application of Aptamers for Targeted Therapeutics. Arch. Immunol. Ther. Exp. (Warsz), 2013, 61(4), 255–271.
35. Dassie, J.P.; Giangrande, P.H. Current Progress on Aptamer- Targeted Oligonucleotide Therapeutics. Ther. Deliv., 2013, 4(12), 1527–1546.
36. Liu, Q.; Jin, C.; Wang, Y.; Fang, X.; Zhang, X.; Chen, Z.; Tan, W. Aptamer-Conjugated Nanomaterials for Specific Cancer Cell Recognition and Targeted Cancer Therapy. NPG Asia Materials, 2014, 6, e95.
37. Townshend, B.; Aubry, I.; Marcellus, R.; Gehring, K.; Tremblay, M. An RNA Aptamer That Selectively Inhibits the Enzymatic Activity of Protein Tyrosine Phosphatase 1B in vitro. ChemBio- Chem., 2010, 11, 1583–1593.
38. Kang, D.; Wang, J.; Zhang, W.; Song, Y.; Li, X.; Zou, Y.; Zhu, M.; Zhu, Z.; Chen, F.; Yang, C. J. Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity. PLoS One, 2012, 7(10), e42731.
39. Xu, W.; Siddiqui, I.; Nihal, M.; Pilla, S.; Rosenthal, K.; Mukhtar, H.; Gong, S. Aptamer-Conjugated and Doxorubicin-Loaded Unimolecular Micelles for Targeted Therapy of Prostate Cancer. Biomaterials, 2013, 34(21), 5244–5253.
40. Cao, H.-Y.; Yuan, A.-H.; Chen, W.; Shi, X.-S.; Miao, Y. A DNA Aptamer with High Affinity and Specificity for Molecular Recognition and Targeting Therapy of Gastric Cancer. BMC Cancer, 2014, 14:699.
41. Hoon, S.; Zhou, B.; Janda, K.; Brenner, S.; Scolnick, J. Aptamer Selection by High-Throughput Sequencing and Informatic Analysis. Biotechniques, 2011, 51(6), 413-416.
42. Mosing, R.K.; Mendonsa, S.D.; Bowser, M.T. Capillary Electrophoresis- SELEX Selection of Aptamers with Affinity for HIV-1 Reverse Transcriptase. Anal. Chem., 2005, 77(19), 6107–6112.
43. Thiel, W.H.; Bair, T.; Peek, A.S.; Liu, X.; Dassie, J.; Stockdale, K.R.; Behlke, M.A.; Miller, F.J. Jr.; Giangrande, P.H. Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection. PLoS One, 2012, 7(9), e43836.
44. Latulippe, D.R.; Szeto, K.; Ozer, A.; Duarte, F.M.; Kelly, C.V.; Pagano, J.M.; White, B.S.; Shalloway, D.; Lis, J.T.; Craighead, H.G. Multiplexed Microcolumn-Based Process for Efficient Selection of RNA Aptamers. Anal. Chem., 2013, 85(6), 3417–3424.
45. Pan, W.; Xin, P.; Patrick, S.; Dean, S.; Keating, C.; Clawson, G. Primer-Free Aptamer Selection Using A Random DNA Library. J. Vis. Exp., 2010, 41, 2039.
46. Wengerter, B.C.; Katakowski, J.A.; Rosenberg, J.M.; Park, C.G.; Almo, S.C.; Palliser, D.; Levy, M. Aptamer-Targeted Antigen Delivery. Mol. Ther., 2014, 22(7), 1375–1387.
47. Zhang, Z.; Ali, M.M.; Eckert, M.A.; Kang, D.K.; Chen, Y.Y.; Sender, L.S.; Fruman, D.A.; Zhao, W. A Polyvalent Aptamer System for Targeted Drug Delivery. Biomaterials, 2013, 34(37), 9728–9735.
48. Meyer, S.; Maufort, J.P.; Nie, J.; Stewart, R.; McIntosh, B.E.; Conti, L.R.; Ahmad, K.M.; Soh, H.T.; Thomson, J.A. Development of an Efficient Targeted Cell-SELEX Procedure for DNA Aptamer Reagents. PLoS One, 2013, 8(8), e71798.
49. Ninomiya, K.; Kaneda, K.; Kawashima, S.; Miyachi, Y.; Ogino, C.; Shimizu, N. Cell-SELEX Based Selection and Characterization of DNA Aptamer Recognizing Human Hepatocarcinoma. Bioorg. Med. Chem. Lett., 2013, 23(6), 1797–1802.
50. Cibiel, A.; Quang, N.N.; Gombert, K.; Thézé, B.; Garofalakis, A.; Ducongé, F. From Ugly Duckling to Swan: Unexpected Identification from Cell-SELEX of an Anti-Annexin A2 Aptamer Targeting Tumors. PLoS One, 2014, 9(1), e87002.
51. Butz, K.; Denk, C.; Ullmann, A.; Scheffner, M.; Hoppe-Seyler, F. Induction of Apoptosis in Human Papillomaviruspositive Cancer Cells by Peptide Aptamers Targeting the Viral E6 Oncoprotein. Proc. Nat. Acad. Sci. U.S.A., 2000, 97(12), 6693–6697.
52. Parekh, P.; Kamble, S.; Zhao, N.; Zeng, Z.; Portier, B.P.; Zu, Y. Immunotherapy of CD30-Expressing Lymphoma Using a Highly Stable ssDNA Aptamer. Biomaterials, 2013, 34(35), 8909–8917.
53. Yu, C.; Hu, Y.; Duan, J.; Yuan, W.; Wang, C.; Xu, H.; Yang, X.D. Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro. PLoS One, 2011, 6(9), e24077.
54. Shieh, Y.A.; Yang, S.J.; Wei, M.F.; Shieh, M.J. Aptamer-Based Tumor-Targeted Drug Delivery for Photodynamic Therapy. ACS Nano, 2010, 4(3), 1433–1442.
55. Charoenphol, P.; Bermudez, H. Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery. Mol. Pharm., 2014, 11(5), 1721–1725.
56. Min, K.; Jo, H.; Song, K.; Cho, M.; Chun, Y.S.; Jon, S.; Kim, W.J.; Ban, C. Dual-Aptamer-Based Delivery Vehicle of Doxorubicin to Both PSMA (+) and PSMA (−) Prostate Cancers. Biomaterials, 2011, 32(8), 2124–2132.
57. Tan, L.; Neoh, K.G.; Kang, E.T.; Choe, W.S.; Su, X. PEGylated Anti-MUC1 Aptamer-Doxorubicin Complex for Targeted Drug Delivery to MCF7 Breast Cancer Cells. Macromol. Biosci., 2011, 11(10), 1331–1335.
58. Hu, Y.; Duan, J.; Zhan, Q.; Wang, F.; Lu, X.; Yang, X.-D. Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro. PLoS One, 2012, 7(2): e31970.
59. Huang, Y.F.; Shangguan, D.; Liu, H.; Phillips, J.A.; Zhang, X.; Chen, Y.; Tan, W. Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells. ChemBioChem 2009, 10(5), 862–868.
60. Kim, E.; Jung, Y.; Choi, H.; Yang, J.; Suh, J.S.; Huh, Y.M.; Kim, K.; Haam, S. Prostate Cancer Cell Death Produced by the Co- Delivery of Bcl-xL shRNA and Doxorubicin Using an Aptamer- Conjugated Polyplex. Biomaterials, 2010, 31(16), 4592–4599.
61. Meng, L.; Yang, L.; Zhao, X.; Zhang, L.; Zhu, H.; Liu, C.; Tan, W. Targeted Delivery of Chemotherapy Agents Using a Liver Cancer- Specific Aptamer. PLoS One, 2012, 7(4), e33434.
62. Subramanian, N.; Raghunathan, V.; Kanwar, J.R.; Kanwar, R. K.; Elchuri, S. V.; Khetan, V.; Krishnakumar, S. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer. Mol. Vis., 2012, 18, 2783-2795.
63. Chang, M.; Yang, C. S.; Huang, D.M. Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy. ACS Nano, 2011, 5(8), 6156–6163.
64. Afonin, K.; Viard, M.; Koyfman, A.; Martins, A.; Kasprzak, W.; Panigaj, M.; Desai, R.; Santhanam, A.; Grabow, W.; Jaeger, L.; Eliahu H.; Jakob R.; Wah C.; Eric O. F.; Bruce A. S. Multifunctional RNA Nanoparticles. Nano Lett., 2014, 14, 5662–5671.
65. Liu, Z.; Duan, J.H.; Song, Y.M.; Jie D; Wang, F.D.; Lu, X.; Yang, X.D. Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-Positive Breast Cancer Cells in Vitro. J. Transl. Med., 2012, 10, 148.
66. Ni, X.; Zhang, Y.; Ribas, J.; Chowdhury, W.H.; Castanares, M.; Zhang, Z.; Laiho, M.; DeWeese, T.L.; Lupold, S.E. Prostate- Targeted Radiosensitization via Aptamer-shRNA Chimeras in Human Tumor Xenografts. J. Clin. Invest., 2011, 121(6), 2383–2390.
67. Rahimi, F.; Murakami, K.; Summers, J.L.; Chen, C.H.; Bitan, G. RNA Aptamers Generated against Oligomeric Aβ40 Recognize Common Amyloid Aptatopes with Low Specificity but High Sensitivity. PLoS One, 2009, 4(11), e7694.
68. Farrar, C.T.; William, C.M.; Hudry, E.; Hashimoto, T.; Hyman, B.T. RNA Aptamer Probes as Optical Imaging Agents for the Detection of Amyloid Plaques. PLoS One, 2014, 9(2), e89901.
69. Yang, D.; Meng, X.; Yu, Q.; Xu, L.; Long, Y.; Liu, B.; Fang, X.; Zhu, H. Inhibition of Hepatitis C Virus Infection by DNA Aptamer against Envelope Protein. Antimicrob. Agents Chemother., 2013, 57(10), 4937–4944.
70. Yu, X.; Gao, Y.; Xue, B.; Wang, X.; Yang, D.; Qin, Y.; Yu, R.; Liu, N.; Xu, L.; Fang, X.; Zhu, H. Inhibition of Hepatitis C Virus Infection by NS5A-Specific Aptamer. Antiviral Res., 2014, 106, 116–124.
71. Ng, E.W.; Shima, D.T.; Calias, P.; Cunningham, E.T.; Guyer, D.R.; Adamis, A.P. Pegaptanib, a Targeted Anti-VEGF Aptamer for Ocular Vascular Disease. Nat. Rev. Drug Discov., 2006, 5(2), 123–132.
72. Pastor, F.; Soldevilla, M.M.; Villanueva, H.; Kolonias, D.; Inoges, S.; de Cerio, A.L.; Kandzia, R.; Klimyuk, V.; Gleba, Y.; Gilboa, E.; Bendandi, M. CD28 Aptamers as Powerful Immune Response Modulators. Mol. Ther. Nucleic Acids, 2013, 2, e98.
73. Trahtenherts, A.; Gal-Tanamy, M.; Zemel, R.; Bachmatov, L.; Loewenstein, S.; Tur-Kaspa, R.; Benhar, I. Inhibition of Hepatitis C Virus RNA Replicons by Peptide Aptamers. Antiviral Res., 2008, 77(3), 195–205.
74. Shi, S.; Yu, X.; Gao, Y.; Xue, B.; Wu, X.; Wang, X.; Yang, D.; Zhu, H. Inhibition of Hepatitis C Virus Production by Aptamers against the Core Protein. J. Virol., 2013, 88(4), 1990–1999.
75. Gao, Y.; Yu, X.; Xue, B.; Zhou, F.; Wang, X.; Yang, D.; Liu, N.; Xu, L.; Fang, X.; Zhu, H. Inhibition of Hepatitis C Virus Infection by DNA Aptamer against NS2 Protein. PLoS One, 2014, 9(2), e90333.
76. Gronewold, T.M.; Baumgartner, A.; Hierer, J.; Sierra, S.; Blind, M.; Schä fer, F.; Blü mer, J.; Tillmann, T.; Kiwitz, A.; Kaiser, R.; Zabe-Kuhn, M.; Quandt, E.; Famulok, M. Kinetic Binding Analysis of Aptamers Targeting HIV-1 Proteins by a Combination of a Microbalance Array and Mass Spectrometry (MAMS). J. Proteome Res., 2009, 8(7), 3568–3577.
77. Chaloin, L.; Lehmann, M.J.; Sczakiel, G.; Restle, T. Endogenous Expression of a High-Affinity Pseudoknot RNA Aptamer Suppresses Replication of HIV-1. Nucleic Acids Res., 2002, 30(18), 4001–4008.
78. Zhou, J.; Shu, Y.; Guo, P.; Smith, D.D.; Rossi, J.J. Dual Functional RNA Nanoparticles Containing phi29 Motor pRNA and Antigp120 Aptamer for Cell-Type Specific Delivery and HIV-1 Inhibition. Methods, 2011, 54(2), 284–294.
79. Zhou, J.; Li, H.; Li, S.; Zaia, J.; Rossi, J.J. Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy. Mol. Ther., 2008, 16(8), 1481–1489.
80. Cui, Z.Q.; Ren, Q.; Wei, H.P.; Chen, Z.; Deng, J.Y.; Zhang, Z.P.; Zhang, X.E. Quantum Dot–aptamer Nanoprobes for Recognizing and Labeling Influenza A Virus Particles. Nanoscale, 2011, 3(6), 2454-2457.
81. Barfod, A.; Persson, T.; Lindh, J. In Vitro Selection of RNA Aptamers against a Conserved Region of the Plasmodium Falciparum Erythrocyte Membrane Protein 1. Parasitol. Res., 2009, 105(6), 1557–1566.
82. Famulok, M. Turning Aptamers into Anticoagulants. Nat. Biotechnol., 2004, 22(11), 1373–1374.
83. Keefe, A.D.; Schaub, R.G. Aptamers as Candidate Therapeutics for Cardiovascular Indications. Curr. Opin. Pharmacol., 2008, 8(2), 147–152.
84. Povsic, T.J.; Sullenger, B.A.; Zelenkofske, S.L.; Rusconi, C.P.; Becker, R.C. Translating Nucleic Acid Aptamers to Antithrombotic Drugs in Cardiovascular Medicine. J.Cardiovasc. Transl. Res., 2010, 3(6), 704–716.
85. Rangnekar, A.; Zhang, A.M.; Li, S.S.; Bompiani, K.M.; Hansen, M.N.; Gothelf, K.V.; Sullenger, B.A.; LaBean, T.H. Increased Anticoagulant Activity of Thrombin-Binding DNA Aptamers by Nanoscale Organization on DNA Nanostructures. Nanomedicine, 2012, 8(5), 673–681.
86. So, Y.H.; Chang, H.T.; Chiu, W.J.; Huang, C.C. Graphene Oxide Modified with Aptamer-Conjugated Gold Nanoparticles and Heparin: A Potent Targeted Anticoagulant. Biomat. Sci,. 2014, 2, 1332-1337.
87. Zavyalova, E.; Samoylenkova, N.; Revishchin, A.; Golovin, A.; Pavlova, G.; Kopylov, A. Evaluation of Antithrombotic Activity of Thrombin DNA Aptamers by a Murine Thrombosis Model. PLoS One, 2014, 9(9), e107113.
88. Shigdar, S.; Lin, J.; Yu, Y.; Pastuovic, M.; Wei, M.; Duan, W. RNA Aptamer against a Cancer Stem Cell Marker Epithelial Cell Adhesion Molecule. Cancer Sci., 2011, 102(5), 991–998.
89. Jalalian, S.H.; Taghdisi, S.M.; Hamedani, N.S.; Kalat, S.A.; Lavaee, P.; Zandkarimi, M.; Ghows, N.; Jaafari, M.R.; Naghibi, S.; Danesh, N.M.; Ramezani, M.; Abnous, K. Epirubicin Loaded Super Paramagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugate for Combined Colon Cancer Therapy and Imaging in Vivo. Eur. J. Pharm. Sci,. 2013, 50(2), 191–197.
90. Fan, Z.; Senapati, D.; Singh, A.K.; Ray, P.C. Theranostic Magnetic Core–Plasmonic Shell Star Shape Nanoparticle for the Isolation of Targeted Rare Tumor Cells from Whole Blood, Fluorescence Imaging, and Photothermal Destruction of Cancer. Mol. Pharm., 2013, 10(3), 857–866.
91. Pilapong, C.; Sitthichai, S.; Thongtem, S.; Thongtem, T. Smart Magnetic Nanoparticle-Aptamer Probe for Targeted Imaging and Treatment of Hepatocellular Carcinoma. Int. J. Pharm., 2014, 473(1-2), 469–474.
92. Zhu, G.; Zheng, J.; Song, E.; Donovan, M.; Zhang, K.; Liu, C.; Tan, W. Self-Assembled, Aptamer-Tethered DNA Nanotrains for Targeted Transport of Molecular Drugs in Cancer Theranostics. Proc. Nat. Acad. Sci. U.S.A., 2013, 110(20), 7998–8003.
93. Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., Zhang, Q. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials, 2012, 33(20): 5115-5123.
94. Li, X.; Yu, Y.; Ji, Q.; Qiu, L. Targeted Delivery of Anticancer Drugs by Aptamer AS1411 Mediated Pluronic F127/cyclodextrin- Linked Polymer Composite Micelles. Nanomedicine, 2015, 11(1), 175–184.
95. Wu, C.; Han, D.; Chen, T.; Peng, L.; Zhu, G.; You, M.; Qiu, L.; Sefah, K.; Zhang, X.; Tan, W. Building a Multifunctional Aptamer- Based DNA Nanoassembly for Targeted Cancer Therapy. J. Am. Chem. Soc., 2013, 135(49), 18644–18650.
96. Lu, W.; Singh, A. K.; Khan, S.A.; Senapati, D.; Yu, H.; Ray, P.C. Gold Nano-Popcorn-Based Targeted Diagnosis, Nanotherapy Treatment, and In Situ Monitoring of Photothermal Therapy Response of Prostate Cancer Cells Using Surface-Enhanced Raman Spectroscopy. J. Am. Chem. Soc., 2010, 132(51), 18103–18114.
97. Jo, H.; Youn, H.; Lee, S.; Ban, C. Ultra-Effective Photothermal Therapy for Prostate Cancer Cells Using Dual Aptamer-Modified Gold Nanostars. J. Mat. Chem. B, 2014, 2, 4862-4867.
98. Li, J.; Zhong, X.; Cheng, F.; Zhang, J.R.; Jiang, L.P.; Zhu, J.J. One-Pot Synthesis of Aptamer-Functionalized Silver Nanoclusters for Cell-Type-Specific Imaging. Anal. Chem., 2012, 84(9), 4140–4146.
99. Lee, I.H.; An, S.; Yu, M.K.; Kwon, H.K.; Im, S.H.; Jon, S. Targeted Chemoimmunotherapy Using Drug-Loaded Aptamer–dendrimer Bioconjugates. J. Control. Release, 2011, 155(3), 435–441.
100. Zhen, S.J.; Zhuang, H.L.; Wang, J.; Huang, C.Z. Dual-Aptamer- Based Sensitive and Selective Detection of Prion Protein through the Fluorescence Resonance Energy Transfer between Quantum Dots and Graphene Oxide. Anal. Methods, 2013, 5, 6904-6907.
101. Bagalkot, V.; Zhang, L.; Levy-Nissenbaum, E.; Jon, S.; Kantoff, P.W.; Langer, R.; Farokhzad, O.C. Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer. Nano Lett., 2007, 7(10), 3065–3070.
102. Savla, R.; Taratula, O.; Garbuzenko, O.; Minko, T. Tumor Targeted Quantum Dot-Mucin 1 Aptamer-Doxorubicin Conjugate for Imaging and Treatment of Cancer. J. Control. Release, 2011, 153(1), 16–22.
103. Das, M.; Duan, W.; Sahoo, S. Multifunctional nanoparticle–EpCAM Aptamer Bioconjugates: A Paradigm for Targeted Drug Delivery and Imaging in Cancer Therapy. Nanomedicine, 2014, 11(2): 379-389.
104. McGinely, N.L.; Plumb, J.A.; Wheate, N.J. DNA-Based Aptamer Fails as a Simultaneous Cancer Targeting Agent and Drug Delivery Vehicle for a Phenanthroline-Based platinum (II) Complex. J. Inorg. Biochem., 2013, 128, 124–130.
105. Yoshida, Y.; Sakai, N.; Masuda, H.; Furuichi, M.; Nishikawa, F.; Nishikawa, S.; Mizuno, H.; Waga, I. Rabbit Antibody Detection with RNA Aptamers. Anal. Biochem., 2008, 375(2), 217–222.
106. Missailidis, S.; Thomaidou, D.; Borbas, K.E.; Price, M.R. Selection of Aptamers with High Affinity and High Specificity against C595, an Anti-MUC1 IgG3 Monoclonal Antibody, for Antibody Targeting. J. Immunol. Methods, 2005, 296(1-2), 45–62.
107. Zichel, R.; Chearwae, W.; Pandey, G.S.; Golding, B.; Sauna, Z.E. Aptamers as a Sensitive Tool to Detect Subtle Modifications in Therapeutic Proteins. PLoS One, 2012, 7(2), e31948.